dc.relation.reference | 1. 行政院衛生署, 1982-2004年癌症死因之統計資料.
2. Chen, C.J., et al., Epidemiologic characteristics and multiple risk factors of lung cancer in Taiwan. Anticancer Res, 1990. 10(4): p. 971-6.
3. Pisani, P., et al., Estimates of the worldwide mortality from 25 cancers in 1990. Int J Cancer, 1999. 83(1): p. 18-29.
4. Chiou, H.L., et al., The presence of human papillomavirus type 16/18 DNA in blood circulation may act as a risk marker of lung cancer in Taiwan. Cancer, 2003. 97(6): p. 1558-63.
5. Madigan, M.P., et al., Proportion of breast cancer cases in the United States explained by well-established risk factors. J Natl Cancer Inst, 1995. 87(22): p. 1681-5.
6. Munoz, N., et al., Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med, 2003. 348(6): p. 518-27.
7. Reichman R.C., B.E., Fauci AS, Kasper DL, Hauser SL, Longo DL, Jameson JL, Human Papillomavirus. Harrison's priciples of internal medicine (15th edition) New York: McGraw-Hill, 2001: p. 1118-1120.
8. Clavel, C.E., et al., Detection of human papillomavirus DNA in bronchopulmonary carcinomas by hybrid capture II: a study of 185 tumors. Cancer, 2000. 88(6): p. 1347-52.
9. Stremlau, A., et al., Human papillomavirus type 16 related DNA in an anaplastic carcinoma of the lung. Cancer, 1985. 55(8): p. 1737-40.
10. Bejui-Thivolet, F., et al., Detection of human papillomavirus DNA in squamous bronchial metaplasia and squamous cell carcinomas of the lung by in situ hybridization using biotinylated probes in paraffin-embedded specimens. Hum Pathol, 1990. 21(1): p. 111-6.
11. Yousem, S.A., N.P. Ohori, and E. Sonmez-Alpan, Occurrence of human papillomavirus DNA in primary lung neoplasms. Cancer, 1992. 69(3): p. 693-7.
12. Ogura, H., et al., Human papillomavirus DNA in squamous cell carcinomas of the respiratory and upper digestive tracts. Jpn J Clin Oncol, 1993. 23(4): p. 221-5.
13. Xing, L.Q., H.R. Liu, and J.Y. Si, [Detection of human papillomavirus DNA in squamous cell carcinomas of the lung by multiple polymerase chain reaction]. Zhonghua Jie He He Hu Xi Za Zhi, 1993. 16(5): p. 275-7, 319.
14. Shamanin, V., H. Delius, and E.M. de Villiers, Development of a broad spectrum PCR assay for papillomaviruses and its application in screening lung cancer biopsies. J Gen Virol, 1994. 75 ( Pt 5): p. 1149-56.
15. Szabo, I., et al., Human papillomavirus not found in squamous and large cell lung carcinomas by polymerase chain reaction. Cancer, 1994. 73(11): p. 2740-4.
16. Xing, L.Q., H.R. Liu, and J.Y. Si, [Analysis of the characteristics of human papilloma virus infection in 85 neoplasms of the respiratory system in adult patients]. Zhonghua Zhong Liu Za Zhi, 1994. 16(6): p. 424-7.
17. Kinoshita, I., et al., Human papillomavirus type 18 DNA and E6-E7 mRNA are detected in squamous cell carcinoma and adenocarcinoma of the lung. Br J Cancer, 1995. 71(2): p. 344-9.
18. Thomas, P., et al., Detection of human papillomavirus DNA in primary lung carcinoma by nested polymerase chain reaction. Cell Mol Biol (Noisy-le-grand), 1995. 41(8): p. 1093-7.
19. Hirayasu, T., et al., Human papillomavirus DNA in squamous cell carcinoma of the lung. J Clin Pathol, 1996. 49(10): p. 810-7.
20. Thomas, P., et al., [Detection of human papillomavirus by polymerase chain reaction in primary lung carcinoma]. Bull Cancer, 1996. 83(10): p. 842-6.
21. Papadopoulou, K., et al., Detection of human papillomaviruses in squamous cell carcinomas of the lung. Virchows Arch, 1998. 433(1): p. 49-54.
22. Tsuhako, K., et al., Human papillomavirus DNA in adenosquamous carcinoma of the lung. J Clin Pathol, 1998. 51(10): p. 741-9.
23. McKaig, R.G., R.S. Baric, and A.F. Olshan, Human papillomavirus and head and neck cancer: epidemiology and molecular biology. Head Neck, 1998. 20(3): p. 250-65.
24. Hu, K., et al., [Detection of human papillomavirus types 16, 18 DNA related sequences in bronchogenic carcinoma]. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, 1997. 11(2): p. 147-9.
25. Zafer, E., et al., Detection and typing of human papillomavirus in non-small cell lung cancer. Respiration, 2004. 71(1): p. 88-90.
26. Kaya, H., et al., Prevalence of human papillomavirus (HPV) DNA in larynx and lung carcinomas. Pathologica, 2001. 93(5): p. 531-4.
27. Iwamasa, T., et al., Prognostic implication of human papillomavirus infection in squamous cell carcinoma of the lung. Pathol Res Pract, 2000. 196(4): p. 209-18.
28. Castillo, A., et al., Human papillomavirus in lung carcinomas among three Latin American countries. Oncol Rep, 2006. 15(4): p. 883-8.
29. Di Lonardo, A., A. Venuti, and M.L. Marcante, Human papillomavirus in breast cancer. Breast Cancer Res Treat, 1992. 21(2): p. 95-100.
30. Bratthauer, G.L., F.A. Tavassoli, and T.J. O'Leary, Etiology of breast carcinoma: no apparent role for papillomavirus types 6/11/16/18. Pathol Res Pract, 1992. 188(3): p. 384-6.
31. Wrede, D., et al., Absence of HPV 16 and 18 DNA in breast cancer. Br J Cancer, 1992. 65(6): p. 891-4.
32. Gopalkrishna, V., et al., Absence of human papillomavirus DNA in breast cancer as revealed by polymerase chain reaction. Breast Cancer Res Treat, 1996. 39(2): p. 197-202.
33. Yu, Y., et al., HPV33 DNA in premalignant and malignant breast lesions in Chinese and Japanese populations. Anticancer Res, 1999. 19(6B): p. 5057-61.
34. Yu, Y., et al., Human papillomavirus type 33 DNA in breast cancer in Chinese. Breast Cancer, 2000. 7(1): p. 33-6.
35. Liu, Y., et al., Human papillomavirus DNA is present in a subset of unselected breast cancers. J Hum Virol, 2001. 4(6): p. 329-34.
36. Kan, C.Y., et al., Identification of human papillomavirus DNA gene sequences in human breast cancer. Br J Cancer, 2005. 93(8): p. 946-8.
37. Burd, E.M., Human papillomavirus and cervical cancer. Clin Microbiol Rev, 2003. 16(1): p. 1-17.
38. 行政院衛生署, 民國九十年癌症登記年報. 2001.
39. Wood, M.E., et al., The inherited nature of lung cancer: a pilot study. Lung Cancer, 2000. 30(2): p. 135-44.
40. Chen, Y.C., et al., Lung adenocarcinoma and human papillomavirus infection. Cancer, 2004. 101(6): p. 1428-36.
41. Ko, Y.C., et al., Chinese food cooking and lung cancer in women nonsmokers. Am J Epidemiol, 2000. 151(2): p. 140-7.
42. Nelson, H.H., et al., k-ras mutation and occupational asbestos exposure in lung adenocarcinoma: asbestos-related cancer without asbestosis. Cancer Res, 1999. 59(18): p. 4570-3.
43. Pershagen, G., et al., Residential radon exposure and lung cancer in Sweden. N Engl J Med, 1994. 330(3): p. 159-64.
44. Pope, C.A., 3rd, et al., Particulate air pollution as a predictor of mortality in a prospective study of U.S. adults. Am J Respir Crit Care Med, 1995. 151(3 Pt 1): p. 669-74.
45. Wu-Williams, A.H., et al., Lung cancer among women in north-east China. Br J Cancer, 1990. 62(6): p. 982-7.
46. Koo, L.C. and J.H. Ho, Worldwide epidemiological patterns of lung cancer in nonsmokers. Int J Epidemiol, 1990. 19 Suppl 1: p. S14-23.
47. Seow, A., et al., Fumes from meat cooking and lung cancer risk in Chinese women. Cancer Epidemiol Biomarkers Prev, 2000. 9(11): p. 1215-21.
48. Li, Q., et al., Detection of human papillomavirus types 16, 18 DNA related sequences in bronchogenic carcinoma by polymerase chain reaction. Chin Med J (Engl), 1995. 108(8): p. 610-4.
49. Cheng, Y.W., et al., Gender difference in human papillomarvirus infection for non-small cell lung cancer in Taiwan. Lung Cancer, 2004. 46(2): p. 165-70.
50. Cheng, Y.W., et al., The association of human papillomavirus 16/18 infection with lung cancer among nonsmoking Taiwanese women. Cancer Res, 2001. 61(7): p. 2799-803.
51. Fei, Y., et al., Different human papillomavirus 16/18 infection in chinese non-small cell lung cancer patients living in wuhan, china. Jpn J Clin Oncol, 2006. 36(5): p. 274-9.
52. Hennig, E.M., et al., HPV positive bronchopulmonary carcinomas in women with previous high-grade cervical intraepithelial neoplasia (CIN III). Acta Oncol, 1999. 38(5): p. 639-47.
53. Wu, M.F., et al., Frequent p16INK4a promoter hypermethylation in human papillomavirus-infected female lung cancer in Taiwan. Int J Cancer, 2005. 113(3): p. 440-5.
54. Soini, Y., et al., Presence of human papillomavirus DNA and abnormal p53 protein accumulation in lung carcinoma. Thorax, 1996. 51(9): p. 887-93.
55. Terry, M.B., et al., Lifetime alcohol intake and breast cancer risk. Ann Epidemiol, 2006. 16(3): p. 230-40.
56. Lahmann, P.H., et al., Long-term weight change and breast cancer risk: the European prospective investigation into cancer and nutrition (EPIC). Br J Cancer, 2005. 93(5): p. 582-9.
57. Michels, K.B., et al., Preschool diet and adult risk of breast cancer. Int J Cancer, 2006. 118(3): p. 749-54.
58. Okobia, M.N., et al., Case-control study of risk factors for breast cancer in Nigerian women: a pilot study. East Afr Med J, 2005. 82(1): p. 14-9.
59. Ursin, G., et al., Reproductive factors and subtypes of breast cancer defined by hormone receptor and histology. Br J Cancer, 2005. 93(3): p. 364-71.
60. Hartmann, L.C., et al., Benign breast disease and the risk of breast cancer. N Engl J Med, 2005. 353(3): p. 229-37.
61. Kowalzick, L., et al., Recurrent papillomas of the nipple associated with human papillomavirus 41. Br J Dermatol, 1990. 122(6): p. 757-62.
62. Damin, A.P., et al., Evidence for an association of human papillomavirus and breast carcinomas. Breast Cancer Res Treat, 2004. 84(2): p. 131-7.
63. Hennig, E.M., et al., Human papillomavirus 16 in breast cancer of women treated for high grade cervical intraepithelial neoplasia (CIN III). Breast Cancer Res Treat, 1999. 53(2): p. 121-35.
64. Widschwendter, A., et al., Detection of human papillomavirus DNA in breast cancer of patients with cervical cancer history. J Clin Virol, 2004. 31(4): p. 292-7.
65. Band, V., et al., Human papilloma virus DNAs immortalize normal human mammary epithelial cells and reduce their growth factor requirements. Proc Natl Acad Sci U S A, 1990. 87(1): p. 463-7.
66. Band, V., et al., Loss of p53 protein in human papillomavirus type 16 E6-immortalized human mammary epithelial cells. J Virol, 1991. 65(12): p. 6671-6.
67. Wazer, D.E., et al., Immortalization of distinct human mammary epithelial cell types by human papilloma virus 16 E6 or E7. Proc Natl Acad Sci U S A, 1995. 92(9): p. 3687-91.
68. Dalal, S., et al., Mutational analysis of human papillomavirus type 16 E6 demonstrates that p53 degradation is necessary for immortalization of mammary epithelial cells. J Virol, 1996. 70(2): p. 683-8.
69. Cook, J.R., et al., Squamous cell carcinoma arising in recurrent respiratory papillomatosis with pulmonary involvement: emerging common pattern of clinical features and human papillomavirus serotype association. Mod Pathol, 2000. 13(8): p. 914-8.
70. Reidy, P.M., et al., Integration of human papillomavirus type 11 in recurrent respiratory papilloma-associated cancer. Laryngoscope, 2004. 114(11): p. 1906-9.
71. Crook, T., J.A. Tidy, and K.H. Vousden, Degradation of p53 can be targeted by HPV E6 sequences distinct from those required for p53 binding and trans-activation. Cell, 1991. 67(3): p. 547-56.
72. Heck, D.V., et al., Efficiency of binding the retinoblastoma protein correlates with the transforming capacity of the E7 oncoproteins of the human papillomaviruses. Proc Natl Acad Sci U S A, 1992. 89(10): p. 4442-6.
73. Dalstein, V., et al., Persistence and load of high-risk HPV are predictors for development of high-grade cervical lesions: a longitudinal French cohort study. Int J Cancer, 2003. 106(3): p. 396-403.
74. Dong, S.M., et al., Detection and quantitation of human papillomavirus DNA in the plasma of patients with cervical carcinoma. Cancer Epidemiol Biomarkers Prev, 2002. 11(1): p. 3-6.
75. Pao, C.C., et al., Detection of human papillomavirus mRNA and cervical cancer cells in peripheral blood of cervical cancer patients with metastasis. J Clin Oncol, 1997. 15(3): p. 1008-12.
76. Bjorge, T., et al., A prospective, seroepidemiological study of the role of human papillomavirus in esophageal cancer in Norway. Cancer Res, 1997. 57(18): p. 3989-92.
77. Han, C., et al., Serologic association between human papillomavirus type 16 infection and esophageal cancer in Shaanxi Province, China. J Natl Cancer Inst, 1996. 88(20): p. 1467-71.
78. Syrjanen, K.J., HPV infections and oesophageal cancer. J. Clin. Pathol., 2002. 55: p. 721-728.
79. Kamangar, F., et al., Human papillomavirus serology and the risk of esophageal and gastric cancers: Results from a cohort in a high-risk region in China. Int J Cancer, 2006. 119(3): p. 579-84.
80. Xu, W.G., et al., [Detection of human papillomavirus type 16 E6 mRNA in carcinomas of upper digestive tract]. Zhonghua Yi Xue Za Zhi, 2003. 83(21): p. 1910-4.
81. Scinicariello, F., et al., Detection of human papillomavirus in primary hepatocellular carcinoma. Anticancer Res, 1992. 12(3): p. 763-6.
82. Bodaghi, S., et al., Colorectal papillomavirus infection in patients with colorectal cancer. Clin Cancer Res, 2005. 11(8): p. 2862-7.
83. Zhang, J., et al., [Expression of human papillomavirus 16 E7 DNA in patients with colorectal adenocarcinoma]. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi, 2005. 22(5): p. 1024-6, 1044.
84. Zhu, Q., J. Cao, and S. Li, [Detection of human papillomavirus gene in biopsies from colon carcinoma by PCR]. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, 1999. 13(4): p. 352-4. | zh_TW |